The overexpression of AC in groups leading to an increase in the lipolysis in adipose tissue and also the expression levels of AC were increased in groups received FSK with mevastatin; this improves the ability of FSK to protect also against obesity. Here, ASAH1 is linked to obesity due to melanocortin 4 receptor deficiency.